Related Experiment Video
Updated: Jan 21, 2026

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids
Published on: April 13, 2022
A comparative study of curated contents by knowledge-based curation system in cancer clinical sequencing
Kazuko Sakai1, Masayuki Takeda2, Shigeki Shimizu3
1Department of Genome Biology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, 589-8511, Japan.
Abstract:
Medical oncologists are challenged to personalize medicine with scientific evidence, drug approvals, and treatment guidelines based on sequencing of clinical samples using next generation sequencer (NGS). Knowledge-based curation systems have the potential to help address this challenge. We report here the results of examining the level of evidence regarding treatment approval and clinical trials between recommendations made by Watson for Genomics (WfG), QIAGEN Clinical Insight Interpret (QCII), and Oncomine knowledge-based reporter (OKR). The tumor samples obtained from the solid cancer patients between May to June 2018 at Kindai University Hospital. The formalin-fixed paraffin-embedded tumor samples (n = 31) were sequenced using Oncomine Comprehensive Assay v3. Variants including copy number alteration and gene fusions identified by the Ion reporter software were used commonly on three curation systems. Curation process of data were provided for 25 solid cancers using three curation systems independently. Concordance and distribution of curated evidence levels of variants were analyzed. As a result of sequencing analysis, nonsynonymous mutation (n = 58), gene fusion (n = 2) or copy number variants (n = 12) were detected in 25 cases, and subsequently subjected to knowledge-based curation systems (WfG, OKR, and QCII). The number of curated information in any systems was 51/72 variants. Concordance of evidence levels was 65.3% between WfG and OKR, 56.9% between WfG and QCII, and 66.7% between OKR and QCII. WfG provided great number of clinical trials for the variants. The annotation of resistance information was also observed. Larger differences were observed in clinical trial matching which could be due to differences in the filtering process among three curation systems. This study demonstrates knowledge-based curation systems (WfG, OKR, and QCII) could be helpful tool for solid cancer treatment decision making. Difference in non-concordant evidence levels was observed between three curation systems, especially in the information of clinical trials. This point will be improved by standardized filtering procedure and enriched database of clinical trials in Japan.
Insights
This study compared three knowledge-based curation systems for personalized cancer medicine. While all systems aided treatment decisions, Watson for Genomics offered more clinical trial information, highlighting the need for standardized data and databases.
Area of Science:
- Oncology
- Genomics
- Bioinformatics
Background:
- Personalizing cancer medicine requires integrating scientific evidence, drug approvals, and treatment guidelines.
- Next-generation sequencing (NGS) generates complex data that necessitates sophisticated interpretation tools.
- Knowledge-based curation systems aim to assist medical oncologists in making evidence-based treatment decisions.
Purpose of the Study:
- To evaluate and compare the evidence levels and clinical trial information provided by three knowledge-based curation systems: Watson for Genomics (WfG), QIAGEN Clinical Insight Interpret (QCII), and Oncomine knowledge-based reporter (OKR).
- To assess the concordance of variant curation and evidence levels across these systems for solid cancer patients.
Main Methods:
- Sequencing of 31 formalin-fixed paraffin-embedded solid tumor samples using the Oncomine Comprehensive Assay v3.
- Identification of variants including nonsynonymous mutations, gene fusions, and copy number alterations using Ion reporter software.
- Independent curation of identified variants using WfG, QCII, and OKR systems, followed by analysis of concordance and evidence levels.
Main Results:
- A total of 58 nonsynonymous mutations, 2 gene fusions, and 12 copy number variants were detected and curated across the three systems.
- The number of curated variants varied, with 51 out of 72 variants receiving curation in at least one system.
- Evidence level concordance was moderate, ranging from 56.9% to 66.7% between system pairs. WfG provided a higher number of clinical trial matches.
- Significant differences were observed in clinical trial matching, potentially due to variations in filtering processes and database content.
Conclusions:
- Knowledge-based curation systems (WfG, OKR, QCII) can be valuable tools for supporting solid cancer treatment decisions.
- Discrepancies in evidence levels, particularly concerning clinical trial information, were noted between the systems.
- Standardizing filtering procedures and enhancing Japanese clinical trial databases are recommended for improved accuracy and utility.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Stereotype Content Model
Hypertension III: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes

